Insights


Managing Treatment Decisions for Ovarian Cancer

December 23rd 2017

Updates in Advanced Gastric/GEJ Cancer Treatment

December 22nd 2017

Case-Based Insights on Multiple Myeloma

December 8th 2017

The Evolving Role of PARP Inhibitors in Ovarian Cancer

November 20th 2017

Collaborative Care in Soft Tissue Sarcoma

November 14th 2017

CDK4/6 Inhibitors for Hormone-Driven Breast Cancer

October 2nd 2017

Addressing Unmet Needs in Liver Cancer

September 8th 2017

Liquid Biopsy Use in Metastatic Non-Small Cell Lung Cancer

August 29th 2017

Minimal Residual Disease Assessment in Lymphoid Malignancies

August 29th 2017

The Evolving Landscape of Therapy for Follicular Lymphoma

August 15th 2017

AR-V7 Testing in Prostate Cancer

July 31st 2017

Optimal Therapeutic Management of Mantle Cell Lymphoma

July 26th 2017

Future Strategies in Kidney Cancer Treatment

July 17th 2017

The Evolving Landscape of Immunotherapy for NSCLC

July 13th 2017

Checkpoint Inhibitors in Head and Neck Cancer

July 7th 2017

Expert Perspective on Treatment of Polycythemia Vera

May 31st 2017

Managing Chemotherapy Toxicity for 5-FU and Capecitabine

May 30th 2017

Current Approaches in Advanced Non-Driver Lung Adenocarcinoma

May 12th 2017

New Treatment Regimens for Previously Treated Myeloma

April 28th 2017

Next-Generation Agents for ALK-Positive NSCLC

April 27th 2017